Radx-tech - ellume USA, LLC point-of-care covid-19 antigen test for the direct detection of the sars COV-2 virus.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00034
- Awardee
-
Ellume USA LLC UEI LC8WE4G8U773 Part of Ellume PTY LTD
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $26,900,000
Award facts
- Contract value 100% obligated
- $26,900,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,050,000 | |
| Funding Only Action | -$3,500,000 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $3,500,000 | |
| Definitize Letter Contract | $17,970,000 | |
| Original award | $11,980,000 |
About this award
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded Ellume USA LLC, a foreign-owned, self-certified small disadvantaged business, a $26,900,000 firm-fixed-price contract for the development of a point-of-care COVID-19 antigen test for the direct detection of the SARS-CoV-2 virus. This contract, part of the RADX-TECH program, has a completion date of March 29, 2023 and does not have a set-aside designation. Ellume USA LLC is a subsidiary of the Australian company Ellume PTY LTD. In addition, the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Ellume USA LLC an Other Transaction (OT) Indefinite Delivery Vehicle (IDV) with a potential value of $283,858,070.93 for the procurement of COVID-19 diagnostic testing prototypes.
Quick answers
Who was awarded contract 75N92020C00034?
75N92020C00034 was awarded to Ellume USA LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 30, 2020.
How much is contract 75N92020C00034 worth?
The government has obligated $26,900,000 on 75N92020C00034.
Was contract 75N92020C00034 competed?
The extent of competition for 75N92020C00034 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award